A Randomized Trial of Buccal Compared to Oral Misoprostol Following Mifepristone for Medical Abortion up to 63 Days LMP
Status:
Completed
Trial end date:
2007-03-01
Target enrollment:
Participant gender:
Summary
This open-label, randomized study will compare the efficacy, safety, and acceptability of
mifepristone 200 mg followed in 24-36 hours either by buccal (i.e., in the cheeks) or oral
misoprostol 800 mcg for termination of pregnancy in women up to 63 days L.M.P.